David Nicholson

Operational Partner

David Nicholson is a recognized leader in Pharmaceutical R&D. Most recently he served as Executive Vice President and Chief R&D Officer of Allergan. Previously, he served as Chief Technology Officer and EVP, R&D for a division at Bayer; Vice President of Licensing and Knowledge Management at Merck; and Senior Vice President, responsible for Global Project Management and Drug Safety at Schering-Plough. From 1988 to 2007, Dr. Nicholson held various leadership positions at Organon, where he most recently served as Executive Vice President, Research & Development and was a member of the company’s Executive Management Committee. He received a B.Sc. from the University of Manchester and his Ph.D. from the University of Wales.

Other Venture&Growth Members

Professor Dr. Rene Bernards

Operational Partner

Professor Dr René Bernards brings extensive experience in oncology as a researcher and a serial entrepreneur. He is a Professor at the Netherlands Cancer Institute (NKI). He performed his post-doctoral research at the Massachusetts Institute...

Michael R. Jaff, DO

Operational Partner

Michael R. Jaff, DO is the Chief Medical Officer and Vice-President of clinical affairs, technology and innovation at Boston Scientific Corporation. A professor of medicine at Harvard Medical School, Dr. Jaff was the President of...

Zosia van Eesteren

Analyst

Zosia van Eesteren is a Dutch national who joined Gilde in 2022. She focuses on the Therapeutics sector and is responsible for analyzing both private and publicly traded companies. She is involved in the identification,...

All team members

David Nicholson - Gilde Healthcare

David Nicholson

Other Venture&Growth Members

Professor Dr. Rene Bernards

Michael R. Jaff, DO

Zosia van Eesteren